Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure-Reference-Cited by-同舟云学术

Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure

Published:2019-12 Issue:12 Volume:21 Page:1651-1658
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Ponikowski Piotr¹²,Kirwan Bridget‐Anne³⁴,Anker Stefan D.⁵,Dorobantu Maria⁶,Drozdz Jarosław⁷,Fabien Vincent⁸,Filippatos Gerasimos⁹,Haboubi Teba⁸,Keren Andre¹⁰,Khintibidze Irakli¹¹,Kragten Hans¹²,Martinez Felipe A.¹³,McDonagh Theresa¹⁴,Metra Marco¹⁵,Milicic Davor¹⁶,Nicolau José C.¹⁷,Ohlsson Marcus¹⁸,Parhomenko Alexander¹⁹,Pascual‐Figal Domingo A.²⁰,Ruschitzka Frank²¹,Sim David²²,Skouri Hadi²³,Meer Peter²⁴,Jankowska Ewa A.¹

Affiliation:

1. Department of Heart DiseasesWrocław Medical University Wrocław Poland

2. Center for Heart Diseases, Military Hospital Wroclaw Poland

3. Department of Clinical ResearchSOCAR Research SA Nyon Switzerland

4. London School of Hygiene and Tropical MedicineUniversity College London London UK

5. Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin Germany

6. Cardiology Department, Emergency Hospital of Bucharest Bucharest Romania

7. Klinika Kardiologii, Uniwersytet Medyczny w Łodzi Lodz Poland

8. Vifor Pharma Opfikon Switzerland

9. Department of Cardiology, Heart Failure UnitNational and Kapodistrian University of Athens Athens Greece

10. Assuta Hashalom Heart InstituteAssuta Hospitals Tel‐Aviv Israel

11. Aleksandre Aladashvili Clinic, LLC Tbilisi Georgia

12. Molenberglaan Heerlen The Netherlands

13. Universidad Nacional de Córdoba, International Society of Cardiovascular Pharmacotherapy Córdoba Argentina

14. King's College Hospital London UK

15. CardiologyUniversity of Brescia and Civil Hospital Brescia Italy

16. University Hospital Centre Zagreb Zagreb Croatia

17. Faculdade de Medicina FMUSPInstituto do Coracao (InCor), Universidade de Sao Paulo Sao Paulo Brazil

18. Department of Nephrology and TransplantationSkane University Hospital Malmoe Malmo Sweden

19. The M.D. Strazhesko Institute of Cardiology Kyiv Ukraine

20. Cardiology Department, Hospital Virgen de la ArrixacaUniversity of Murcia Murcia Spain

21. UniversitätsSpietal Zürich, Klinik für Kardiologie Zürich Switzerland

22. National Heart Centre, Clinical Translational and Research Office Singapore Singapore

23. American University of Beirut, Medical Center Beirut Beirut Lebanon

24. Department of CardiologyUniversity Medical Center Groningen Groningen The Netherlands

Funder

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1710

Reference52 articles.

1. Heart failure: preventing disease and death worldwide

2. In-hospital worsening heart failure

3. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome

4. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

5. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between iron status markers and kidney outcome in patients with chronic kidney disease;Scientific Reports;2023-10-25

2. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial;Cardiovascular Diabetology;2023-08-17

3. Association between iron status markers and kidney outcome in patients with chronic kidney disease;2023-08-10

4. Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function;Clinical Journal of the American Society of Nephrology;2023-06-29

5. Clinical study on the relationship between gut microbiota dysbiosis and iron metabolism and septic cardiomyopathy;2023-06-27